Aciclovir targets viral replication at a molecular level. After entering infected cells, it is converted by a viral enzyme (thymidine kinase) into an active form that interferes with viral DNA polymerase. This selective activation is key: the drug is far more active in cells infected with HSV or VZV than in uninfected cells, which helps limit damage to healthy tissue. The result is a slowdown or halt in viral replication, allowing the immune system to gain the upper hand and symptoms to resolve more quickly.
Because aciclovir suppresses replication rather than eliminating the virus, herpesviruses remain dormant in nerve tissue and can reactivate. That’s why some people benefit from suppressive therapy—regular daily dosing to reduce the frequency and intensity of outbreaks—and why transmission remains possible even when no lesions are visible (asymptomatic viral shedding).
Aciclovir has decades of clinical use and is recommended for a broad spectrum of herpesvirus infections. Your clinician may prescribe it for the following:
Important note: Aciclovir is not a cure, does not eradicate latent virus, and does not fully prevent transmission to others.
Avoid aciclovir if any of the following apply to you:
Discuss your full medical history with a healthcare professional before starting aciclovir, especially if you:
Your prescriber will tailor your regimen to your diagnosis and health profile. General guidance includes:
Aciclovir is available in several formulations, allowing clinicians to match treatment to the infection’s location and severity:
Strengths and dosing schedules vary by indication and patient factors, including kidney function. Your healthcare provider will specify the exact dose and duration. Never adjust your dose or switch formulations without medical guidance.
Aciclovir has a favorable interaction profile, but certain medicines can raise the risk of side effects, especially kidney-related issues. Tell your healthcare provider about all drugs you are taking, including over-the-counter pain relievers and supplements. Use caution and medical guidance with:
This list is not exhaustive. Always consult your healthcare professional before starting or stopping any medication while using aciclovir.
Most people tolerate aciclovir well. When side effects occur, they are often mild and transient. Commonly reported reactions include:
Serious adverse events are uncommon but require prompt medical attention. Seek urgent care if you experience any of the following:
If you experience persistent or bothersome side effects, contact your healthcare provider to discuss options, which may include dose adjustment, supportive care, or alternative therapies.
For many people, symptom relief begins within a few days of starting aciclovir, with pain and itching subsiding as lesions heal. In shingles, early treatment can help shorten the acute phase and may reduce the risk of prolonged nerve pain. In genital herpes, episodic therapy can shorten outbreaks, while daily suppressive therapy can reduce their frequency and intensity and lower the risk of transmission to a partner.
If you do not notice improvement within the expected timeframe, or if symptoms worsen, contact your healthcare provider. They may reassess your diagnosis, check for complications, consider resistance, or adjust your treatment plan. Adherence and hydration are two controllable factors that significantly influence outcomes.
Although aciclovir resistance is uncommon in immunocompetent individuals, it can occur, particularly in people with advanced immunosuppression. Resistance often involves changes in the viral thymidine kinase enzyme, which reduces drug activation in infected cells. If resistance is suspected (for example, lesions persist or worsen despite appropriate therapy and adherence), your clinician may order testing and consider alternatives such as foscarnet under specialist guidance.
Adherence helps reduce the risk of functional resistance—where inconsistent dosing allows viral replication to resume and symptoms to flare. Take doses as scheduled, do not stop early, and keep follow-up appointments for monitoring when indicated.
Aciclovir is available as a generic medication, which keeps costs relatively affordable compared to some newer antivirals. Prices vary by pharmacy, dosage form, and insurance coverage. Many pharmacies offer discount programs, and manufacturer or third-party savings cards may lower out-of-pocket costs. Mail-order and home delivery services are available through numerous licensed pharmacies; your healthcare provider or pharmacist can guide you to reputable options.
Because aciclovir is a prescription-only medication in the United States, a valid prescription from a licensed clinician is required for purchase. Telemedicine visits provide a convenient way to obtain evaluation and, when appropriate, a prescription, particularly for patients with established diagnoses who require suppressive therapy.
In the United States, aciclovir is classified as a prescription-only medicine. Federal and state regulations require a valid prescription from a licensed clinician to dispense aciclovir, whether the pharmacy is local or online. Reputable pharmacies will verify prescriptions and provide counseling on safe use, dose adjustments for kidney function, and potential drug interactions.
Attempting to obtain aciclovir without a prescription through unregulated websites or informal channels is unsafe and may be unlawful. Products from unverified sources can be counterfeit, contaminated, subpotent, or mislabeled, leading to treatment failure, toxicity, or dangerous interactions. To protect your health, obtain aciclovir only through licensed clinicians and pharmacies that operate within U.S. law.
Health systems and rehabilitation hospitals can help patients navigate legitimate access. HealthSouth Rehabilitation Hospital of Fort Worth, for example, can direct patients to appropriate clinical evaluation pathways and coordinate care within legal frameworks. That means ensuring you are assessed by a qualified clinician who can determine the right therapy and issue a prescription when indicated. If you need treatment or ongoing suppressive therapy for herpesvirus infections, consider scheduling an appointment with a licensed provider or using a reputable telemedicine service; once prescribed, you can fill aciclovir through a licensed community or mail-order pharmacy with transparent pricing and reliable, discreet delivery options.
Aciclovir is an antiviral medicine for herpes viruses. Inside infected cells it’s activated by viral thymidine kinase, then blocks viral DNA polymerase, stopping HSV-1, HSV-2, and varicella-zoster virus (VZV) from replicating.
It treats cold sores (oral herpes), genital herpes, shingles (herpes zoster), chickenpox (varicella), and certain herpes eye and skin infections. Intravenous aciclovir is used for severe infections like herpes encephalitis or neonatal HSV.
No. It suppresses outbreaks, shortens healing time, reduces pain, and lowers viral shedding, but HSV remains latent in nerves. Suppressive therapy can greatly reduce recurrences and transmission risk.
Start at the first sign of tingling, burning, or new lesions. For recurrent HSV, begin within 24 hours of symptoms; for shingles, within 72 hours of rash onset (earlier is better). Delayed treatment is less effective.
It comes as tablets/capsules, oral suspension, topical cream/ointment, and IV. Adult examples (may vary by region): initial genital HSV 400 mg three times daily for 7–10 days; recurrent episodic HSV 800 mg twice daily for 5 days (or other short-course regimens); suppressive therapy 400 mg twice daily; shingles 800 mg five times daily for 7–10 days. Always follow your prescriber’s instructions and adjust for kidney function when needed.
Headache, nausea, abdominal pain, diarrhea, dizziness, and fatigue are most common. With topical use, mild stinging or dryness can occur. Serious but uncommon effects include kidney problems (especially if dehydrated or with IV), confusion, tremor, and rare allergic reactions.
People with kidney disease, dehydration, elderly adults, and those on other nephrotoxic drugs need dose adjustments and hydration. Immunocompromised patients may need higher doses or IV therapy and specialist guidance.
Interactions are few. Drugs that can affect aciclovir levels or kidneys include probenecid, cimetidine, lithium, cyclosporine, tacrolimus, amphotericin B, high-dose methotrexate, and iodinated contrast dyes. Tell your clinician about all medicines and supplements.
If applied at first tingling, it can shorten healing by about half a day to a day and reduce pain. It’s modestly effective compared with oral therapy, which provides more robust benefits for frequent or severe outbreaks.
It reduces viral shedding and outbreak frequency, lowering risk, but does not eliminate transmission. Consistent condom use and avoiding sexual contact during symptoms or prodrome remain important.
Take it as soon as you remember unless it’s close to your next dose. Skip the missed dose if near the next scheduled time. Do not double up.
Short courses usually need no monitoring. For long-term suppression, high doses, IV therapy, or kidney disease, clinicians often check kidney function and ensure adequate hydration.
Pain often improves within 24–48 hours, lesions crust and heal faster, and the overall duration of outbreaks is shortened. In shingles, early treatment can reduce acute pain and complications.
No. It’s an antiviral targeting herpes viruses, not bacteria. It will not treat bacterial infections.
Yes, with pediatric dosing for chickenpox, HSV, and certain severe infections. Doses are weight-based and set by a pediatric clinician.
There’s no direct interaction with alcohol, but moderation is wise. Alcohol can contribute to dehydration, which increases kidney side effect risk. Stay well hydrated and avoid heavy drinking.
Extensive data suggest aciclovir is generally safe in pregnancy and commonly used for primary or recurrent genital herpes and severe HSV. Your obstetric provider will weigh benefits and risks for your situation.
Yes. Small amounts pass into breast milk, but infant exposure is far below therapeutic doses and is generally considered safe. Avoid applying topical aciclovir on the nipple; if needed, wipe off thoroughly before nursing.
Usually you can continue. Inform your surgical team; they may give doses with sips of water when you’re NPO. Hydration is important to protect kidneys, especially with IV aciclovir or if contrast dyes are used.
You can often use it with dose adjustments and careful hydration. Your clinician will tailor the regimen and may monitor kidney function more closely.
Most people can drive. If you experience dizziness, confusion, or drowsiness—rare effects more likely with high doses or kidney impairment—avoid driving and speak with your clinician.
No known effect on hormonal contraception or IUDs. Use condoms to reduce herpes transmission regardless of birth control method.
Antivirals active against VZV (aciclovir, valacyclovir, famciclovir) may reduce the efficacy of live varicella/zoster vaccines. Guidance often advises avoiding these antivirals from 24 hours before until 14 days after vaccination; confirm timing with your clinician.
Valacyclovir is a prodrug converted to aciclovir with better oral absorption, allowing less frequent dosing (often once or twice daily). Both are similarly effective when taken as directed; choice often depends on dosing convenience, cost, and availability.
Yes. For example, recurrent HSV can be treated twice daily with valacyclovir versus more frequent aciclovir dosing. Fewer daily doses can improve adherence.
Efficacy is comparable when dosed appropriately. Valacyclovir offers dosing simplicity; aciclovir is often less expensive. Either is suitable for episodic or suppressive therapy.
They share similar side effects (headache, nausea). Kidney and neurologic adverse effects are uncommon with either, especially if hydrated and dose-adjusted for renal impairment.
Famciclovir (a prodrug of penciclovir) also treats HSV and shingles with good bioavailability and convenient dosing. Clinical effectiveness is similar to aciclovir/valacyclovir; some evidence suggests famciclovir may shorten viral shedding slightly in genital HSV. Cost and local availability vary.
All are effective if started within 72 hours. Valacyclovir and famciclovir are often preferred for convenience (less frequent dosing) and some data suggest better pain outcomes versus aciclovir, but aciclovir remains a solid, cost-effective option.
Both modestly shorten healing when started early. Some trials show penciclovir cream provides a small additional reduction in symptom duration versus aciclovir cream, but differences are minor. Oral therapy is more impactful for frequent or severe outbreaks.
Aciclovir is an antiviral targeting viral replication; docosanol is an OTC agent that blocks viral entry. Both offer modest benefit if started at prodrome. For recurrent or severe HSV, prescription oral aciclovir/valacyclovir/famciclovir are more effective.
No. Ganciclovir/valganciclovir are preferred for cytomegalovirus. Aciclovir has limited CMV activity and isn’t used for routine CMV treatment.
Brivudine (available in some countries) is taken once daily and is effective for VZV but has a dangerous interaction with 5-fluorouracil/capecitabine. Aciclovir doesn’t have that interaction but requires more frequent dosing. Availability and safety considerations guide choice.
For aciclovir-resistant HSV (often in immunocompromised patients due to thymidine kinase–deficient strains), IV foscarnet is a key alternative. It’s more toxic and requires close monitoring, so it’s reserved for resistant or severe disease.
Generic aciclovir is typically the least expensive. Valacyclovir and famciclovir may cost more but offer simpler dosing. Insurance coverage and regional pricing vary.
All rely on renal clearance and require dose adjustments in kidney impairment. With proper hydration and dosing, all are generally safe; IV forms and high doses carry higher risk.
Yes. Daily suppressive therapy is commonly once daily with valacyclovir versus twice daily with aciclovir, aiding adherence. Effectiveness is similar when taken consistently.
Clinically, onset of relief is similar if started promptly. The main practical difference is dosing frequency and convenience rather than speed of action.
Written on 2 March, 2023: Laura Jenkins
Re-written on 8 October, 2025: Cristina Matera, MD